OTC Markets OTCPK - Delayed Quote USD
Ginkgo Bioworks Holdings, Inc. (DNABW)
At close: November 7 at 2:55 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Jason Kelly | Founder, CEO & Director | 262.5k | -- | 1981 |
| Dr. Reshma P. Shetty | Founder, President, COO & Director | 262.5k | -- | 1981 |
| Mr. Mark E. Dmytruk | Chief Financial Officer | 476.5k | -- | 1971 |
| Mr. Thomas Knight Jr. | Founder | -- | -- | -- |
| Mr. Austin Che Ph.D. | Founder, Head of Strategy & Treasurer | -- | -- | -- |
| Mr. Bartholomew Canton | Founder, CTO & Secretary | -- | -- | -- |
| Mr. Steven P. Coen CPA | Chief Accounting Officer | -- | -- | -- |
| Ms. Anna Marie Wagner M.B.A. | Senior Vice President of Corporate Development | -- | -- | 1990 |
| Ms. Samantha Sutton | Head of People | -- | -- | -- |
| Mr. Joshua Dunn | Head of Design | -- | -- | -- |
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
United States
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 1,218
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Corporate Governance
Ginkgo Bioworks Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
CTX.WA Captor Therapeutics Spolka Akcyjna
63.00
-4.26%
BAI.AS BenevolentAI S.A.
0.7800
+4.00%
GNTA Genenta Science S.p.A.
4.8600
+0.62%
TVGNW Tevogen Bio Holdings Inc.
0.0640
+27.49%
ONT.L Oxford Nanopore Technologies plc
133.10
+1.29%
ALLR Allarity Therapeutics, Inc.
1.4000
-1.41%
CGEN Compugen Ltd.
1.8100
+5.23%
IMUX Immunic, Inc.
1.1800
0.00%
BMRN BioMarin Pharmaceutical Inc.
66.94
+1.19%
MESO Mesoblast Limited
8.64
-1.03%